Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Crypto Trading Hamster Who Outperformed Warren Buffett Is Back From The Dead And Buying Dogecoin

Mr. Goxx — the cryptocurrency trading hamster — is back to live-streaming his daily trades on Amazon Inc's (NASDAQ: AMZN) video streaming service Twitch.

Benzinga

Why Kornit Digital Shares Are Plunging Today

Kornit Digital Ltd (NASDAQ:KRNT) reported first-quarter revenue growth of 26% year-over-year to $83.3 million, missing the consensus of $87.81 million. Adjusted EPS of $0.00 missed the consensus of $0.15. The gross margin contracted by 590 bps to 40.1%. The adjusted gross margin was 41.5%, down 557 bps. Kornit Digital reported an operating…

Benzinga

Redbox Entertainment Stock Halted Several Times: What's Going On?

Redbox Entertainment Inc (NASDAQ: RDBX) shares are extremely volatile on Wednesday. The stock is trading narrowly lower after initially falling more than 50% following a takeover announcement.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For Zealand Pharma

Zealand Pharma (NASDAQ:ZEAL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Zealand Pharma will report an earnings per share (EPS) of $-0.94.

Benzinga

Expert Ratings for TPG

Within the last quarter, TPG (NASDAQ:TPG) has observed the following analyst ratings:

Benzinga

WAVE Life Sciences Earnings Preview

WAVE Life Sciences (NASDAQ:WVE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that WAVE Life Sciences will report an earnings per share (EPS) of $-0.55.

Benzinga

Orchard Therapeutics Earnings Preview

Orchard Therapeutics (NASDAQ:ORTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Orchard Therapeutics will report an earnings per share (EPS) of $-0.26.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

OptiNose Earnings Preview

OptiNose (NASDAQ:OPTN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that OptiNose will report an earnings per share (EPS) of $-0.27.

Benzinga

Earnings Outlook For SCYNEXIS

SCYNEXIS (NASDAQ:SCYX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that SCYNEXIS will report an earnings per share (EPS) of $-0.75.

Benzinga

Preview: Virios Therapeutics's Earnings

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios Therapeutics will report an earnings per share (EPS) of $-0.53.

Benzinga

What 4 Analyst Ratings Have To Say About AbCellera Biologics

Over the past 3 months, 4 analysts have published their opinion on AbCellera Biologics (NASDAQ:ABCL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Earnings Outlook For Privia Health Group

Privia Health Group (NASDAQ:PRVA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Privia Health Group will report an earnings per share (EPS) of $-0.04.

Benzinga

Earnings Outlook For Liquidia Technologies

Liquidia Technologies (NASDAQ:LQDA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Liquidia Technologies will report an earnings per share (EPS) of $-0.20.

Benzinga

What 5 Analyst Ratings Have To Say About TechTarget

Over the past 3 months, 5 analysts have published their opinion on TechTarget (NASDAQ:TTGT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Synlogic Earnings Preview

Synlogic (NASDAQ:SYBX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Synlogic will report an earnings per share (EPS) of $-0.24.

Benzinga

Earnings Outlook For DarioHealth

DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth will report an earnings per share (EPS) of $-0.96.

Benzinga

Analyst Ratings for SoFi Technologies

Within the last quarter, SoFi Technologies (NASDAQ:SOFI) has observed the following analyst ratings:

Benzinga

Analyst Ratings for Playtika Holding

Over the past 3 months, 5 analysts have published their opinion on Playtika Holding (NASDAQ:PLTK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Ominous Death Cross Forms On Fortinet's Chart

If history is any guide, there may be trouble ahead for shares of Fortinet (NASDAQ:FTNT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

This Foreboding Sign Looms Over Fox's Chart

If history is any guide, there may be trouble ahead for shares of Fox (NASDAQ:FOX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

5 Value Stocks To Watch In The Industrials Sector

What are Value Stocks?

Benzinga

Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021

Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or $0.50 loss per share. For comparison, net loss in the same period of 2021 was $12.7 million…

Benzinga

First Patient Dosed in Phase 2 Study of Intercept's OCA and Bezafibrate Combination for Primary Biliary Cholangitis

Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) dosed first patient in a Phase 2 study evaluating a fixed-dose combination of obeticholic acid (OCA) and bezafibrate (BZF) for the treatment of patients with primary biliary cholangitis (PBC).

Benzinga

StoneCastle Financial's Earnings Outlook

StoneCastle Financial (NASDAQ:BANX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that StoneCastle Financial will report an earnings per share (EPS) of $0.46.

Benzinga

Earnings Preview For Biolase

Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Biolase will report an earnings per share (EPS) of $-0.68.

1 … 555 556 557 558

People

Warren Buffett

2,104 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Intercept Pharmaceuticals

11 stories

AbCellera Biologics

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.